Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.
What do GPs need to know about ‘walking’ pneumonia? With a current ‘soup’ of respiratory infections coupled with antibiotic shortages, an epidemiologist outlines basic advice for GPs.
Debate over ‘doctor-approved’ weight loss drugs obtained online Is a GP-reviewed online questionnaire clinically sufficient to safely prescribe injectable medications without a face-to-face consultation? It depends who you ask.
Have the benefits of statins been overstated? Researcher Paula Byrne writes on what she and her colleagues learned from a meta-analysis of 21 clinical trials involving 140,000 patients.
How long does immunity last after a COVID infection? Dr Lara Herrero and Wesley Freppel assess the latest evidence, including the impact vaccination and emerging variants can have.
Tongue cancer diagnoses on the rise Rates have spiked in cohorts not traditionally at risk of the cancer, especially younger women with no history of smoking or heavy drinking.
Can a magnesium-rich diet reduce dementia risk? New research suggests there is an association between increased magnesium consumption and healthier brain ageing, with women benefitting the most.
Study compares Mounjaro to Wegovy for weight loss A new clinical trial, sponsored by the manufacturer, found Mounjaro led to greater weight loss, but GPs warn of its ‘risks of biases’.
One of the many faces of codeine addiction Jessica Khachan lives in Sydney with her husband and two kids, who are 14 and 12, in what she describes as ‘a normal suburban household’. She is also one of the increasing number of Australians with a history of codeine addiction.
PBS restrictions placed on diabetes medicines GPs now need to gain additional approval prior to starting patients on all GLP-1 RAs, including semaglutide.